Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2510-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4705 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
filingDate |
2003-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e49e950d006b655019233fc12f1dfa02 |
publicationDate |
2005-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2005013829-A1 |
titleOfInvention |
Novel growth factor Opa1 and uses thereof |
abstract |
The present invention discloses nucleic acids encoding a novel growth factor Opa1, which promotes the regeneration of nervous tissue. Also disclosed are nucleic acids that hybridize to the complementary sequences of nucleic acids encoding Opa1, and vectors comprising said nucleic acids. In addition, the present invention also provides a purified Opa1 protein and methods of using the same. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10580024-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11282098-B2 |
priorityDate |
1999-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |